Found 15 matching trials
A Randomized, Open-label, Double-cohort Study of Fluzoparib Combined With Famitinib Malate or SHR-1701 for Neoadjuvant Therapy in Patients With Advanced Ovarian Cancer PHASE2 This study is a randomized, open-label, double-cohort, national multi-cente...
Show More Location
Multiple Locations
Learn More & Join Trial
Study to Evaluate the Efficacy and Safety of Camrelizumab and Famitinib in Patients With Advanced Solid Tumor PHASE2 This is an open-label, multi-center study to evaluate the anti-tumor activi...
Show More Location
Fudan University Zhongshan Hospital
Learn More & Join Trial
SNF Platform Study of HR+/ HER2-advanced Breast Cancer PHASE2 The purpose of this study is to establish a prospective, multi-center platf...
Show More Location
Breast cancer institute of Fudan University Cancer Hospital
Learn More & Join Trial
Camrelizumab Combined With Famitinib Malate and Chemotherapy for Treatment of Recurrent/ Metastatic Cervical Cancer PHASE2 This study is an open-label, multi-center Phase II clinical study, aimed to...
Show More Location
Multiple Locations
Learn More & Join Trial
A Study of Famitinib in Combination With HS-10296 in Patients With EGFR-mutant NSCLC PHASE2 The study is being conducted to evaluate the efficacy, safety and tolerabil...
Show More Location
Tongji University, Shanghai Pulmonary Hospital
Learn More & Join Trial
Adebrelimab Combined With Famitinib and Irinotecan in Advanced Gastric Cancer After Failure of First-Line Therapy PHASE2 This study employs a randomized, controlled, exploratory clinical trial des...
Show More Location
Shandong First Medical University Affiliated Cancer Hospital
Learn More & Join Trial
SHR-1701 in Combination With Famitinib in Patients With Recurrent/Metastatic Nasopharyngeal Carcinoma PHASE1 This is an open label, multi-center, phase I/II study to evaluate the effic...
Show More Location
Cancer Hospital of Guangzhou Sun Yat-sen University
Learn More & Join Trial
A Prospective, Randomized, Parallel Trial of Famitinib Malate at Different Doses Combined With Camrelizumab for the Treatment of Recurrent and Metastatic Cervical Cancer PHASE2 This study is a prospective, randomized, parallel investigation aimed at ev...
Show More Location
Multiple Locations
Learn More & Join Trial
A Study of Adebrelimab Combined With Famitinib and Chemotherapy in the Treatment of ES-SCLC. PHASE2 This is a single arm, multi-center, phase II trial to evaluate the efficacy...
Show More Location
Multiple Locations
Learn More & Join Trial
A Trial of SHR-1701 in Combination With Famitinib in Patients With Advanced Solid Tumors PHASE1 This is an open-label, multi-center study to evaluate the efficacy and safe...
Show More Location
Anhui Provincial Hospital
Learn More & Join Trial